For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer of existing
shares to which voting rights are attached:
Fuller Smith & Turner PLC
2. Reason for notification [Yes/No]
An acquisition or disposal of voting rights YES
An acquisition or disposal of financial instruments which
may result in the
acquisition of shares already issued to which voting rights
are attached
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to AEGON UK Group of Companies
notification
obligation:
4. Full name of shareholder(s) (if
different from 3):
5. Date of transaction (and date on 18th May 2007
which the
threshold is crossed or reached if
different):
6. Date on which issuer notified: 21st May 2007
7. Threshold(s) that is/are crossed or 3%-4%
reached:
8: Notified Details
A: Voting rights attached to shares
Class/type Situation previous to Resulting situation after
of the triggering the triggering transaction
shares transaction
If possible Number of Number of Number of Number of Percentage of
use shares voting shares voting rights voting rights
ISIN code rights
Direct Indirect Direct Indirect
GB0003551867 512,840 512,840 531,203 531,203 21,837 4.10% 0.17%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ No. of voting Percentage of
financial date conversion rights that may be voting rights
instrument period/date acquired (if the
instrument exerci
sed/converted)
Total (A+B)
Number of voting rights Percentage of voting rights
553,040 4.27%
9. Chain of controlled undertakings through which the voting rights and /or the
financial instruments are effectively held, if applicable:
AEGON UK Group of companies - parent undertaking of:
AEGON Asset Management UK plc
AEGON Investment Management UK ltd.
AEGON ICVC
Proxy Voting:
10. Name of proxy holder: AEGON UK Group of Companies
11. Number of voting rights proxy N/A
holder will cease to hold:
12. Date on which proxy holder will N/A
cease to hold voting rights:
13. Additional information: AEGON UK Group of Companies consists of:
AEGON Asset Management UK plc
AEGON Investment Management UK ltd
AEGON ICVC
14 Contact name: Miranda Beacham
15. Contact telephone name: 0131 549 3460
For notes on how to complete form TR-1 please see the FSA website.
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in shares
A: Identity of the persons or legal entity subject to the notification
obligation
Full name AEGON Asset Management UK plc
(including legal form of legal
entities)
Contact address AEGON House,
(registered office for legal
entities) 3 Lochside Avenue,
Edinburgh Park,
Edinburgh,
EH12 9SA
Phone number & email 0870 60 90 101
Other useful information Ian G Young, Company secretary,
(at least legal representative
for legal persons) 0131 549 6398
B: Identity of the notifier, if applicable
Full name Miranda Beacham
Contact address AEGON House,
3 Lochside Avenue,
Edinburgh Park,
Edinburgh,
EH12 9SA
Phone number & email 0131 549 3460
Other useful information
(e.g. functional relationship
with the
person or legal entity subject
to the
notification obligation)
C: Additional information
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.